When Premi Haynes was growing up in Pune, India, she attended Stella Maris High School, an English language convent school founded by Swiss nuns. Her second grade singing class used a book of English songs. One of the songs was "My Old Kentucky Home." At that time, Haynes had never heard of Kentucky, had no idea where it was, and had no particular ambition to go there.
Some 20 years and a twist of fate later, today Haynes is defending her Ph.D.
Questions continue to come up related to compliance with the NIH Public Access Policy. We are pleased to provide this additional resource as investigators work through the steps to comply with this policy. This PowerPoint is from a presentation at the June 2013 NIH Regional Conference. To view the presentation, click on the file below.
In addition to providing high quality health care, the University of Kentucky is also committed to finding new treatments, tests, and cures for diseases. Now, patients at UK can contribute to that effort by agreeing to participate in the Research Registry and Specimen Bank, or the "biobank."
When you have a medical procedure that involves, for example, drawing blood or sampling tissue, there is often material left over from the testing process that would otherwise be thrown away.
Nearly 700 researchers, students, policymakers and community members will gather at the Lexington Convention Center March 27 to share research, mentor junior faculty, and enhance collaborations in clinical and translational science, with special focus on addressing health disparities in Appalachia.
All active investigators will receive a reminder to update their Financial Disclosure Forms during the month of March. EAG is sending the email in batches. The first was sent on February 18 and they are currently through the S’s.
As a reminder, clinical trial F&A rates for industry-funded studies increased effective 7/1/2013. Please be sure to use this rate in study budgets being discussed with sponsors. Information can be found here: http://www.research.uky.edu/ospa/info/clinical_info.html.
In our continuing effort to keep the College of Medicine informed about the 2014 National Conference on Undergraduate Research http://www.cur.org/ncur_2014/, which will take place here at UK on April 3 – 5, please note the following ways to encourage student participation:
NIH PIs are reminded that compliance with the NIH Public Access Policy is applicable to all awards with start dates July 1, 2013, or later. More information can be found at this link, http://publicaccess.nih.gov/. Also available is a PowerPoint presentation as prepared by Dr. Tom Kelly, Associate Dean for Research, College of Nursing, and Professor, Dept. of Behavioral Science.
Non-competing continuation grants (research and non-research) including those that remain to be issued in FY 2014 likely will be made within the range between the commitment level indicated on the Notice of Award and 3 percent below that level.
The NIH awarding Institutes/Centers (IC) will develop and post their fiscal policies consistent with overall NIH goals and available FY 2014 funds.
Sent on behalf of Brandy Nelson, University of Kentucky Biosafety Officer and Responsible Official:
Per the Code of Federal Regulations (7 CFR Part 331, 9 CFR Part 121, and 42 CFR Part 73) possession, use or transfer of the infectious agents and toxins listed below requires registration with the Centers for Disease Control and Prevention and/or United States Department of Agriculture. Non-compliance with these regulations may result in criminal penalties, including fines and incarceration, affecting the University of Kentucky and/or the individual in possession of the material.
University of Kentucky College of Medicine student Melanie Pleiss has received the PhRMA Foundation Pre-Doctoral Fellowship in Pharmacology/Toxicology.
The fellowship is a two year award that provides recipients with an annual stipend of $20,000 to support the research activities of a doctoral program.
"The application process is extremely competitive, with just one applicant per institution allowed to apply and only a certain number of awards given to U.S. schools of medicine, pharmacy, dentistry or veterinary medicine," said Dr.
For junior faculty with clinical and/or teaching responsibilities, it's difficult to find enough time to prioritize their own research. On top of time constraints, junior faculty members often have limited experience in the precise art of writing successful federal grant applications and managing large grants. It takes time, training, and funding to accelerate a research career. The KL2 Career Development Program provides these resources to investigators to do just that.
A new study led by University of Kentucky Markey Cancer Center researcher Peter Zhou shows that targeting Twist, a nuclear protein that is an accelerant of the epithelial-mesenchymal transition (EMT) program in human cells, may provide an effective approach for treating triple-negative breast cancer.
Triple-negative breast cancer has an activated EMT program, which is a process that provides cells with the increased plasticity (or flexibility) to adapt to stressed environments during embryonic development, wound healing, tissue fibrosis and metastasis.
The Office of Sponsored Projects Administration has created a new webpage entitled "Investigator's Survival Guide". This new page offers guidance to investigators at on topics ranging form Proposal Submission to Responsible Conduct of Research. To view the page, click here.
